Manager, Cellular Immunology
Genovac Antibody Discovery
Research Scientist,
Single B-cell Technology
Genovac Antibody Discovery
Sr. Product Manager,
Antibody Discovery
Berkeley Lights
A Beacon for Rapid Antibody Discovery against Difficult Targets
- Time:
Over the last three decades antibody therapies have been developed against a host of diseases including autoimmune disorders, infectious diseases, and cancer. Traditional technologies, however, have had limited success in delivering antibodies for difficult but highly promising targets, such as GPCRs and ion channels. In this GEN webinar, our panelists from Genovac, will present case studies of how they have overcome these antibody discovery and development challenges by leveraging their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.
A live Q&A session followed the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
